Open to opportunities

PATRICIA CAROLINE

@patriciacaroline

Message

Clinical pharmacist specializing in evidence-based decision support, pharmacovigilance, and PK/PD monitoring.

Brazil

Message

What I'm looking for

I’m looking for a clinical pharmacist role where I can apply evidence-based decision support, active pharmacovigilance, and PK/PD monitoring to strengthen patient safety—open to remote opportunities.

I’m a Clinical Pharmacist trained at HC-FMUSP, with experience in high-complexity hospital environments and accredited healthcare systems (JCI/ONA). I focus on evidence-based clinical decision support, pharmacovigilance, and PK/PD monitoring to protect patients and improve therapeutic outcomes.

At Hospital Samaritano (2024–Present), I validate prescriptions, analyze drug-drug interactions, and optimize therapy. I monitor and evaluate adverse drug reactions through active pharmacovigilance, perform Naranjo Algorithm causality assessments, and apply risk minimization strategies; I handle 150+ prescription items per day, monitor 33+ patients per day, and deliver 60+ clinical interventions per month, including PK/PD monitoring such as vancomycin. I also contribute to JCI accreditation processes.

Previously, as a Clinical Pharmacy Resident at HC-FMUSP (2022–2024), I reviewed prescriptions using evidence-based guidelines, conducted ADR surveillance, and assessed causality with the Naranjo Algorithm. I reported adverse events via Notivisa, classified and coded using MedDRA, built clinical indicators and safety reports, and supported ONA accreditation. Earlier, as a Drug Information Analyst (2018–2022), I developed technical medication content, completed regulatory reviews aligned with ANVISA, and supported clinical protocols including VTE, aspiration, rational use of PPIs, vancomycin monitoring, chest pain, and stroke.

Experience

Work history, roles, and key accomplishments

Current

Clinical Pharmacist

Current

Hospital Samaritano

Jan 2024 - Present (2 years 5 months)

Reviewed 150+ prescriptions/day for 33+ patients/day and performed 60+ clinical interventions/month, delivering evidence-based therapy optimization through drug-drug interaction analysis and active pharmacovigilance. Conducted ADR causality assessment (Naranjo), supported PK/PD monitoring (e.g., vancomycin), and contributed to JCI accreditation processes.

Pharmacovigilance ADR Causality Assessment (Naranjo)PK PD Monitoring Vancomycin Monitoring JCI Accreditation

Clinical Pharmacy Resident

HC-FMUSP

Jan 2022 - Jan 2024 (2 years)

Performed evidence-based clinical prescription review and monitored ADRs through active adverse event surveillance. Conducted Naranjo causality assessments, reported events via Notivisa, coded using MedDRA, and supported ONA accreditation through safety indicators and reports.

ADR Causality Assessment (Naranjo)Notivisa Reporting MedDRA Coding ONA Accreditation

Drug Information Analyst

Consulta Remédios

Jan 2018 - Jan 2022 (4 years)

Developed technical medication content and performed regulatory reviews aligned with ANVISA to support pharmaceutical industry needs. Authored and supported clinical protocols including VTE management, aspiration, rational use of PPIs, vancomycin monitoring, and protocols related to chest pain and stroke.

Drug Information ANVISA Aligned Regulatory Review Clinical Protocol Development Rational Use Of Medicines VTE Protocols PPI Rational Use Guidance Vancomycin Monitoring

Education

Degrees, certifications, and relevant coursework

HC-FMUSP (Hospital das Clínicas da FMUSP)

Clinical Pharmacy Residency, Clinical Pharmacy

2022 - 2024

Activities and societies: Evidence-based medication review; ADR surveillance and causality assessment (Naranjo); reporting via Notivisa; coding with MedDRA; developed clinical indicators and safety reports; participated in ONA accreditation.

Clinical Pharmacy residency at HC-FMUSP focused on evidence-based prescription review and active pharmacovigilance. Monitored and assessed ADRs using the Naranjo Algorithm, supported safety reporting/indicators, and participated in ONA accreditation processes.